Global Influenza Vaccine Market

Global Influenza Vaccine Market is projected to grow at a CAGR of 6.37% to reach US$7.547 billion by 2024, from US$5.209 billion in 2018. Few manufacturers have started developing cell-based influenza vaccines which can be given to egg-allergic individuals, however, they yield of cell culture-based vaccines is relatively limited.

We have covered all segment of this market in our market research report. We are providing some segments briefly here:

By Vaccine Technology

Trivalent

Quadrivalent

By End-User

Children

Adolescents

Adults

Elderly

By Geography

North America

USA

Canada

Mexico

Others

South America

Brazil

Argentina

Others

Europe

Germany

France

United Kingdom

Spain

Others

Middle East and Africa

Saudi Arabia

Israel

Others